Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunosi PK in Breast Milk and Plasma of Postpartum Women
NCT05008341Phase 1Completed
- Sponsor
- Axsome Therapeutics, Inc.
- Start
- Aug 2021
- Primary completion
- Apr 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of solriamfetol in narcolepsy and obstructive sleep apnea (OSA), sponsored by Axsome Therapeutics, Inc. Primary endpoints: Maximum Concentration, Time to Reach Maximum Concentration and 9 more. Started Aug 2021; status: completed.
02
Drugs
solriamfetol
03
Conditions
narcolepsyobstructive sleep apnea (OSA)
Beyond the preview
Go deeper on NCT05008341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05008341.